Koers Heart Test Laboratories, Inc.
Aandelen
HSCS
US42254E3027
Geavanceerde medische apparatuur & technologie
Geschatte realtime
Andere beurzen
|
Variatie 5 dagen | Verschil t.o.v. 1 jan (%) | ||
5,6 USD | -4,76% | -25,79% | -65,67% |
Omzet 2024 * | 59,3K 54,64K | Omzet 2025 * | 1,9 mln. 1,75 mln. | Marktkapitalisatie | 3,86 mln. 3,55 mln. |
---|---|---|---|---|---|
Nettowinst (verlies) 2024 * | -6 mln. -5,53 mln. | Nettowinst (verlies) 2025 * | -9 mln. -8,29 mln. | EV/omzet 2024 * | 65 x |
Nettoliquiditeiten 2024 * | - 0 | Nettoliquiditeiten 2025 * | - 0 | EV/omzet 2025 * | 2,03 x |
K/w-verhouding 2024 * |
-0,29
x | K/w-verhouding 2025 * |
-0,56
x | Werknemers | 12 |
Dividendrendement 2024 * |
-
| Dividendrendement 2025 * |
-
| Vrij verhandelbaar | 83,99% |
1 dag | -4,76% | ||
1 week | -25,79% | ||
Lopende maand | -36,47% | ||
1 maand | -41,24% | ||
3 maanden | -51,04% | ||
6 maanden | -70,07% | ||
Lopend jaar | -65,67% |
Managers | Titel | Leeftijd | Van |
---|---|---|---|
Andrew Simpson
CEO | Chief Executive Officer | 55 | 25-07-13 |
Danielle Watson
DFI | Director of Finance/CFO | 42 | 01-11-21 |
Aaron Peterson
CTO | Chief Tech/Sci/R&D Officer | - | 01-07-14 |
Besturend | Titel | Leeftijd | Van |
---|---|---|---|
Mark Hilz
COO | Chief Operating Officer | 66 | 25-07-13 |
David R. Wells
BRD | Director/Board Member | 61 | 28-12-22 |
Andrew Simpson
CEO | Chief Executive Officer | 55 | 25-07-13 |
Datum | Koers | Variatie | Volume |
---|---|---|---|
21-05-24 | 5,87 | -0,17% | 50 254 |
20-05-24 | 5,88 | -15,64% | 165 778 |
17-05-24 | 6,97 | -38,37% | 348 902 |
16-05-24 | 11,31 | +25,81% | 411 195 |
15-05-24 | 8,99 | +13,65% | 74 210 |
uitgestelde koers Nasdaq, 21 mei 2024 om 18:09 uur
Meer koersenHerzieningen van WPA
Vaira. 1 jan. | Kapi. | |
---|---|---|
-65,67% | 3,86 mln. | |
-14,11% | 2,88 mld. | |
+1,74% | 188 mln. | |
+13,04% | 50,96 mln. |